共 106 条
[1]
Boomer JS(2014)The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence 5 45-56
[2]
Green JM(2016)Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis JAMA 315 1469-1479
[3]
Hotchkiss RS(2011)Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients Int Immunopharmacol 11 2086-2090
[4]
van Vught LA(2009)Gamma-globulin levels in patients with community-acquired septic shock Shock 32 379-385
[5]
Klein Klouwenberg PM(2010)Gamma-globulin levels in patients with community-acquired septic shock Shock 33 556-557
[6]
Spitoni C(1999)Structure and Function of Immunoglobulins Sepsis 3 197-218
[7]
Venet F(2004)Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review Clin Infect Dis 39 38-46
[8]
Gebeile R(2007)Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis Crit Care Med 35 2686-2692
[9]
Bancel J(2007)Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis Ann Intern Med 146 193-203
[10]
Taccone FS(2007)Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock Crit Care Med 35 2677-2678